| scholarly article | Q13442814 |
| P50 | author | Lara Magro | Q57717824 |
| P2093 | author name string | Roberto Leone | |
| Ugo Moretti | |||
| P2860 | cites work | Pharmacogenetics, pharmacogenomics, and individualized medicine | Q23919667 |
| Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients | Q28169189 | ||
| Admissions to a medical intensive care unit related to adverse drug reactions | Q28220337 | ||
| Codeine intoxication associated with ultrarapid CYP2D6 metabolism | Q28300589 | ||
| Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey | Q43853947 | ||
| Drug-drug interactions among elderly patients hospitalized for drug toxicity | Q44388653 | ||
| Drug-drug interactions in cardiac and cardiothoracic intensive care units: an analysis of patients in an academic medical centre in the US. | Q44510140 | ||
| Drug-related deaths in a university central hospital | Q44991872 | ||
| Increasing exposure to drug-drug interactions between 1992 and 2005 in people aged > or = 55 years | Q45026753 | ||
| Drug interactions with the potential to prevent prodrug activation as a common source of irrational prescribing in hospital inpatients | Q45183565 | ||
| Drug-drug and drug-disease interactions in the ED: analysis of a high-risk population | Q45275902 | ||
| Prevalence of drug-drug interactions at hospital entry and during hospital stay of patients in internal medicine. | Q45768952 | ||
| Fatal drug-drug interaction of brivudine and capecitabine | Q46150329 | ||
| Drug-drug interactions as a determinant of elevated lithium serum levels in daily clinical practice. | Q46494859 | ||
| Frequency and clinical relevance of drug interactions with lovastatin and simvastatin: an observational database study | Q46732031 | ||
| Drug interactions with cholinesterase inhibitors: an analysis of the French pharmacovigilance database and a comparison of two national drug formularies (Vidal, British National Formulary). | Q46921603 | ||
| Attitudes among hospital physicians to the reporting of adverse drug reactions in Sweden. | Q50631412 | ||
| Polypharmacy among nursing home geriatric Medicaid recipients. | Q50998761 | ||
| Lack of awareness of community-acquired adverse drug reactions upon hospital admission : dimensions and consequences of a dilemma. | Q51028313 | ||
| Prevention of adverse drug reactions in intensive care patients by personal intervention based on an electronic clinical decision support system. | Q51785199 | ||
| Drug-drug interactions in a geriatric outpatient cohort: prevalence and relevance. | Q51890063 | ||
| Trends in polypharmacy and potential drug-drug interactions across educational groups in elderly patients in Sweden for the period 1992 2002 | Q55953463 | ||
| Potent cytochrome P450 2C19 genotype–related interaction between voriconazole and the cytochrome P450 3A4 inhibitor ritonavir | Q56829869 | ||
| Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes | Q28474740 | ||
| Manufacturer's drug interaction and postmarketing adverse event data: what are appropriate uses? | Q30482229 | ||
| Drug related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention | Q30661684 | ||
| Predicting in vivo drug interactions from in vitro drug discovery data | Q31011412 | ||
| Identifying adverse drug reactions associated with drug-drug interactions: data mining of a spontaneous reporting database in Italy | Q33634312 | ||
| Increasing polypharmacy - an individual-based study of the Swedish population 2005-2008 | Q33760012 | ||
| Fatal hydrocodone overdose in a child: pharmacogenetics and drug interactions. | Q34137741 | ||
| Polypharmacy and combination therapy in the management of hypertension in elderly patients with co-morbid diabetes mellitus | Q34144920 | ||
| Emergency re-admissions to hospital due to adverse drug reactions within 1 year of the index admission | Q34381378 | ||
| Drug related admissions to medical wards: a population based survey | Q34402554 | ||
| Ability of pharmacy clinical decision-support software to alert users about clinically important drug-drug interactions | Q34424127 | ||
| Polypharmacy, adverse drug-related events, and potential adverse drug interactions in elderly patients presenting to an emergency department | Q34446827 | ||
| Hospital admissions resulting from preventable adverse drug reactions | Q34796945 | ||
| Cytochrome p-450 polymorphisms and response to clopidogrel | Q34910228 | ||
| Prospective evaluation of adverse drug interactions in the emergency department | Q35445849 | ||
| Frequency and characteristics of hospital admissions associated with drug-related problems in paediatrics | Q35826144 | ||
| Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems | Q36024341 | ||
| The dosing of atypical antipsychotics | Q36121556 | ||
| Drug interactions between antibiotics and select maintenance medications: seeing more clearly through the narrow therapeutic window of opportunity | Q36428363 | ||
| The utility of adding retrospective medication profiling to computerized provider order entry in an ambulatory care population | Q36463186 | ||
| Polypharmacy as a risk factor for adverse drug reactions in geriatric nursing home residents | Q36490976 | ||
| Detection of potential drug interactions - a model for a national pharmacy register | Q36560351 | ||
| Hospitalisations and emergency department visits due to drug-drug interactions: a literature review | Q36677190 | ||
| The challenge of managing drug interactions in elderly people | Q36880978 | ||
| Polypharmacy in elderly patients | Q37052260 | ||
| Drug interactions in oncology: how common are they? | Q37588305 | ||
| Clopidogrel and proton pump inhibitors: a clinically meaningful interaction? | Q37831269 | ||
| Evaluation of contraindicated drug-drug interaction alerts in a hospital setting | Q37850892 | ||
| Clopidogrel-drug interactions | Q37851658 | ||
| Adverse drug reactions: definitions, diagnosis, and management | Q40739350 | ||
| Important drug-drug interactions in the elderly | Q40854207 | ||
| Drug interaction and pharmacist | Q41904703 | ||
| Classifying drug interactions | Q42759539 | ||
| Severe rhabdomyolysis as a consequence of the interaction of fusidic acid and atorvastatin | Q42871519 | ||
| Adverse drug reactions in hospitalized psychiatric patients | Q43108046 | ||
| Potential drug-drug interactions and admissions due to drug-drug interactions in patients treated in medical departments | Q43137769 | ||
| Fatal lactic acidosis precipitated by nifedipine in a patient treated with disulfiram and antiretrovirals | Q43287167 | ||
| Drug interactions and multiple drug administration | Q43525549 | ||
| Drug-related admissions to an Australian hospital | Q43660776 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | epidemiology | Q133805 |
| drug interaction | Q718753 | ||
| P304 | page(s) | 83-94 | |
| P577 | publication date | 2011-10-25 | |
| P1433 | published in | Expert Opinion on Drug Safety | Q5421206 |
| P1476 | title | Epidemiology and characteristics of adverse drug reactions caused by drug-drug interactions | |
| P478 | volume | 11 |
| Q39209254 | A cross-sectional study on drug use in multiple system atrophy |
| Q45983542 | A dataset quantifying polypharmacy in the United States. |
| Q89893028 | A super-combo-drug test to detect adverse drug events and drug interactions from electronic health records in the era of polypharmacy |
| Q50849068 | Actual drug-drug interactions in elderly patients discharged from internal medicine clinic: a prospective observational study. |
| Q45821018 | Characterisation of non-warfarin-associated bleeding events reported to the Norwegian spontaneous reporting system |
| Q58117113 | Clinical Utility of Definitive Drug⁻Drug Interaction Testing in Primary Care |
| Q36410106 | Clinically important drug-drug interactions in poly-treated elderly outpatients: a campaign to improve appropriateness in general practice |
| Q54261327 | Comparative analysis of three drug-drug interaction screening systems against probable clinically relevant drug-drug interactions: a prospective cohort study. |
| Q58994804 | Comparing Drug-Drug Interaction Severity Ratings between Bedside Clinicians and Proprietary Databases |
| Q36219247 | Consensus recommendations for systematic evaluation of drug-drug interaction evidence for clinical decision support |
| Q33781632 | Data-driven prediction of adverse drug reactions induced by drug-drug interactions. |
| Q36320218 | Detection of drug-drug interactions through data mining studies using clinical sources, scientific literature and social media. |
| Q48158949 | Drug drug interaction extraction from the literature using a recursive neural network |
| Q57787835 | Drug-Drug Interaction Assessment and Identification in the Primary Care Setting |
| Q39472689 | Drug-drug interaction study of ACT-178882, a new renin inhibitor, and diltiazem in healthy subjects |
| Q91620854 | Drug-drug-gene interactions and adverse drug reactions |
| Q91810819 | Effect of an educational intervention on the number potential drug-drug interactions |
| Q93372821 | Evaluation of Clinical Relevance of Drug-Drug Interaction Alerts Prior to Implementation |
| Q49278505 | Formalizing Evidence Type Definitions for Drug-Drug Interaction Studies to Improve Evidence Base Curation. |
| Q38010000 | Frequency of adverse reactions to first- and second-line anti-tuberculosis chemotherapy in a Korean cohort |
| Q34273354 | Genetic variability of drug-metabolizing enzymes: the dual impact on psychiatric therapy and regulation of brain function. |
| Q39198151 | How common are drug and gene interactions? Prevalence in a sample of 1143 patients with CYP2C9, CYP2C19 and CYP2D6 genotyping |
| Q57294178 | Impact of Definitive Drug-Drug Interaction Testing on Medication Management and Patient Care |
| Q45898539 | Importance of cytochrome P450 (CYP450) in adverse drug reactions due to drug-drug interactions: a PharmacoVigilance study in France. |
| Q37527674 | Incidence of Potential Drug-Drug Interactions in a Limited and Stereotyped Prescription Setting - Comparison of Two Free Online Pharmacopoeias |
| Q37225741 | Patient Characteristics Associated with Adverse Drug Events in Hospital: An Overview of Reviews |
| Q27692687 | Pharmacogenomics of Drug Metabolizing Enzymes and Transporters: Relevance to Precision Medicine |
| Q38773723 | Phenobarbital Treatment at a Neonatal Age Results in Decreased Efficacy of Omeprazole in Adult Mice |
| Q38611632 | Potential Drug-Drug Interactions Among Critically Ill Pediatric Patients in a Tertiary Pulmonary Center |
| Q55646748 | Potential Drug-Drug Interactions with Antimicrobials in Hospitalized Patients: A Multicenter Point-Prevalence Study. |
| Q37719619 | Potential drug interactions in patients with a history of cancer |
| Q36120277 | Potential drug-drug interactions among elderly patients admitted to medical ward of Ayder Referral Hospital, Northern Ethiopia: a cross sectional study |
| Q47129567 | Potential drug-drug interactions among hospitalized patients in a developing country |
| Q64926751 | Potential drug-drug interactions and associated factors among hospitalized cardiac patients at Jimma University Medical Center, Southwest Ethiopia. |
| Q57477779 | Potential drug-drug interactions in outpatient department of a tertiary care hospital in Pakistan: a cross-sectional study |
| Q38824529 | Potential drug-drug interactions in paediatric outpatient prescriptions in Nigeria and implications for the future |
| Q59125343 | Potentially serious drug interactions resulting from the pre-travel health encounter |
| Q95840715 | Prevalence and Accuracy of Information on CYP2D6, CYP2C19, and CYP2C9 Related Substrate and Inhibitor Co-Prescriptions in the General Population: A Cross-Sectional Descriptive Study as Part of the PharmLines Initiative |
| Q47643184 | Prevalence of QT interval prolonging drug-drug interactions (QT-DDIs) in psychiatry wards of tertiary care hospitals in Pakistan: a multicenter cross-sectional study. |
| Q36290903 | Prevalence of drug interactions in elderly patients with multimorbidity in primary care |
| Q38398699 | Recommendations to improve the usability of drug-drug interaction clinical decision support alerts |
| Q64061552 | Risk of Drug-Drug Interactions in Out-Hospital Drug Dispensings in France: Results From the DRUG-Drug Interaction Prevalence Study |
| Q57791539 | Stressors and Resources Related to Medication Management: Associations With Spousal Caregivers' Role Overload |
| Q41683801 | Systemic anticancer therapy (SACT) for lung cancer and its potential for interactions with other medicines |
| Q36259408 | Text mining for drug-drug interaction |
| Q40067944 | The prevalence and preventability of potentially relevant drug-drug interactions in patients admitted for cardiovascular diseases: A cross-sectional study. |
| Q26896954 | Toward a complete dataset of drug-drug interaction information from publicly available sources |
| Q36835297 | Using Nonexperts for Annotating Pharmacokinetic Drug-Drug Interaction Mentions in Product Labeling: A Feasibility Study. |
| Q21503276 | Utilizing the Wikidata system to improve the quality of medical content in Wikipedia in diverse languages: a pilot study |
| Q37552063 | VKORC1 and CYP2C9 polymorphisms related to adverse events in case-control cohort of anticoagulated patients |
Search more.